Dedan Opondo
Research Subjects
Dedan Opondo has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
Jean J.M.C.H. de la Rosette
Renal Transplant Unit Department of Internal Medicine Academisch Medisch Centrum Amsterdam The Netherlands
5 shared publicationsGaston Labate
Urosalud, Buenos Aires, Argentina
3 shared publicationsJean de la Rosette
Amsterdam, Netherlands
3 shared publications- Stephanie Medlock
Department of Medical Informatics Amsterdam UMC location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands
3 shared publications Ameen Abu-Hanna
2 shared publications- Ameen Abu-Hanna
Amsterdam UMC location University of Amsterdam Department of Medical Informatics North-Holland
2 shared publications
Latest Publications
- 1 October 2013
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 11 (10) , 1259-1269.e10
Co-prescription of Gastroprotective Agents and Their Efficacy in Elderly Patients Taking Nonsteroidal Anti-inflammatory Drugs: A Systematic Review of Observational Studies
- 1 October 2013
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 11 (10) , 1259-1269.e10
Co-prescription of Gastroprotective Agents and Their Efficacy in Elderly Patients Taking Nonsteroidal Anti-inflammatory Drugs: A Systematic Review of Observational Studies
- Open Access
- 2 July 2013
- Published by Wiley in BJU International
- Vol. 113 (5b) , E49-E55
The 1‐year decline in estimated glomerular filtration rate ( eGFR ) after radical nephrectomy in patients with renal masses and matched living kidney donors is the same
Objectives: To determine short‐term differences in renal function evolution between patients with renal cell carcinoma ( RCC ) submitted to radical nephrectomy ( RN ) and living kidney donors matched for age and gender. To assess the role of co‐morbidity as a risk factor for developing an estimated glomerular filtration rate ( eGFR ) of 2 . Patients and Methods: In this retrospective study patients undergoing Radical Nefrectomy ( RN ) between J anuary 2000 and F ebruary 2011 for suspicion of localised RCC were matched by age and gender to living kidney donors. Renal function was compared between the groups using the Modification in Diet and Renal Disease ( MDRD ) equation at 1 year after RN . Charlson co‐morbidity score, incidence of hypertension, diabetes and cardiovascular disease were compared and assessed as predictors for developing an eGFR of 2 . Results: In all, 196 patients were included, 98 in each group. The mean age was respectively 60.6 ( RCC group) and 59.1 years (donors). The 1‐year postoperative mean eGFR (available in 89 patients with RCC and 87 donors) was similar, at a mean ( sd ) of 56.7 (16.4) mL/min/1.73 m 2 in patients with RCC and 56.2 (9.8) mL/min/1.73 m 2 in donors ( P = 0.83). In patients with RCC the incidence and severity of co‐morbidities was significantly higher. A preoperative eGFR of 60–89 mL/min/1.73 m 2 was the only independent risk factor for developing a postoperative eGFR of 2 (odds ratio 4.4, confidence interval 2.1–9.5, P < 0.001, 95% confidence interval). Conclusions: In our cohorts with advanced age the 1‐year follow‐up eGFR was similar in both groups. Despite increased co‐morbidity in the RCC group there was no increased decline in renal function. Only reduced preoperative eGFR could be identified as risk factor for developing a postoperative eGFR of 2 .
- 2 July 2013
- Published by Wiley in BJU International
- Vol. 113 (5b) , E49-E55
Open AccessThe 1‐year decline in estimated glomerular filtration rate ( eGFR ) after radical nephrectomy in patients with renal masses and matched living kidney donors is the same
Objectives: To determine short‐term differences in renal function evolution between patients with renal cell carcinoma ( RCC ) submitted to radical nephrectomy ( RN ) and living kidney donors matched for age and gender. To assess the role of co‐morbidity as a risk factor for developing an estimated glomerular filtration rate ( eGFR ) of 2 . Patients and Methods: In this retrospective study patients undergoing Radical Nefrectomy ( RN ) between J anuary 2000 and F ebruary 2011 for suspicion of localised RCC were matched by age and gender to living kidney donors. Renal function was compared between the groups using the Modification in Diet and Renal Disease ( MDRD ) equation at 1 year after RN . Charlson co‐morbidity score, incidence of hypertension, diabetes and cardiovascular disease were compared and assessed as predictors for developing an eGFR of 2 . Results: In all, 196 patients were included, 98 in each group. The mean age was respectively 60.6 ( RCC group) and 59.1 years (donors). The 1‐year postoperative mean eGFR (available in 89 patients with RCC and 87 donors) was similar, at a mean ( sd ) of 56.7 (16.4) mL/min/1.73 m 2 in patients with RCC and 56.2 (9.8) mL/min/1.73 m 2 in donors ( P = 0.83). In patients with RCC the incidence and severity of co‐morbidities was significantly higher. A preoperative eGFR of 60–89 mL/min/1.73 m 2 was the only independent risk factor for developing a postoperative eGFR of 2 (odds ratio 4.4, confidence interval 2.1–9.5, P < 0.001, 95% confidence interval). Conclusions: In our cohorts with advanced age the 1‐year follow‐up eGFR was similar in both groups. Despite increased co‐morbidity in the RCC group there was no increased decline in renal function. Only reduced preoperative eGFR could be identified as risk factor for developing a postoperative eGFR of 2 .
- 1 July 2013
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 190 (1) , 149-156
A Nephrolithometric Nomogram to Predict Treatment Success of Percutaneous Nephrolithotomy
Imaging is routinely done preoperatively and postoperatively to assess patients treated with percutaneous nephrolithotomy. We developed a nomogram for percutaneous nephrolithotomy success. From November 2007 to December 2009 the CROES (Clinical Research Office of the Endourological Society) collected data on consecutive patients at 96 centers globally. Patients were evaluated for stone-free status using plain x-ray of the kidneys, ureters and bladder. Treatment success was defined as no visible stones or residual fragments less than 4 mm. Multivariate regression was used to model the relationship between preoperative descriptors and the stone-free rate. Variables included case load, prior treatment, body mass index, staghorn stones, renal anomalies, and stone burden, location and count. Bootstrapping techniques were used to validate the model. Adjusted chi-square statistic values were used to rank the prognostic value of variables. A nomogram was developed using significant predictors from the model. We assessed the predictive accuracy of the nomogram using the ROC curve AUC. The nomogram was calibrated. Stone burden was the best predictor of the stone-free rate (chi-square = 30.27, p <0.001). Other factors associated with the stone-free rate were case volume (chi-square = 35.75, p <0.001), prior stone treatment (chi-square = 14.55, p <0.012), staghorn stone (adjusted chi-square = 4.73, p <0.029), stone location (chi-square = 14.74, p <0.001) and stone count (chi-square = 4.78, p <0.004). A nephrolithometric nomogram was developed with predictive accuracy (AUC 0.76). The percutaneous nephrolithotomy stone-free rate can be predicted using preclinical data and radiological information. We present a nephrolithometric nomogram for percutaneous nephrolithotomy.
- 1 July 2013
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 190 (1) , 149-156
A Nephrolithometric Nomogram to Predict Treatment Success of Percutaneous Nephrolithotomy
Imaging is routinely done preoperatively and postoperatively to assess patients treated with percutaneous nephrolithotomy. We developed a nomogram for percutaneous nephrolithotomy success. From November 2007 to December 2009 the CROES (Clinical Research Office of the Endourological Society) collected data on consecutive patients at 96 centers globally. Patients were evaluated for stone-free status using plain x-ray of the kidneys, ureters and bladder. Treatment success was defined as no visible stones or residual fragments less than 4 mm. Multivariate regression was used to model the relationship between preoperative descriptors and the stone-free rate. Variables included case load, prior treatment, body mass index, staghorn stones, renal anomalies, and stone burden, location and count. Bootstrapping techniques were used to validate the model. Adjusted chi-square statistic values were used to rank the prognostic value of variables. A nomogram was developed using significant predictors from the model. We assessed the predictive accuracy of the nomogram using the ROC curve AUC. The nomogram was calibrated. Stone burden was the best predictor of the stone-free rate (chi-square = 30.27, p <0.001). Other factors associated with the stone-free rate were case volume (chi-square = 35.75, p <0.001), prior stone treatment (chi-square = 14.55, p <0.012), staghorn stone (adjusted chi-square = 4.73, p <0.029), stone location (chi-square = 14.74, p <0.001) and stone count (chi-square = 4.78, p <0.004). A nephrolithometric nomogram was developed with predictive accuracy (AUC 0.76). The percutaneous nephrolithotomy stone-free rate can be predicted using preclinical data and radiological information. We present a nephrolithometric nomogram for percutaneous nephrolithotomy.
- Open Access
- 1 April 2013
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 189 (4S) , e625
1526 A NEPHROLITHOMETRIC NOMOGRAM FOR PREDICTING TREATMENT SUCCESS IN PERCUTANEOUS NEPHROLITHOTOMY
Tion in focal atherosclerotic lesions of the internal pudendal arteries (IPAs) among men with erectile dysfunction (ED) and a suboptimal response to phosphodiesterase-5 inhibitors. Zotarolimus is a cytostatic limus drug that minimizes growth of restenotic cells and preserves healthy endothelial cells lining a cobalt chromium stent. METHODS: We performed a prospective, multicenter, singlearmed safety and feasibility trial of 30 male subjects Ͼ 18 years with atherosclerotic ED and a suboptimal response to phosphodiesterase-5 inhibitors. A novel combination of clinical, duplex ultrasound, and invasive angiographic factors were used to determine eligibility for stent therapy. Key inclusion criteria included IIEF-6 Ͻ 21 with at least 4 weeks of PDE5i use, ultrasound PSVs Ͻ 30 cm/sec bilaterally, and angiographic stenosis of one or both IPAs. Key exclusion criteria included non-vascular causes of ED, venous leak as seen on penile Doppler (EDV Ͼ 5 cm/sec), and arteriographic non target lesions of Ͼ 70% stenosis in common iliac or common penile artery. The primary safety end point was any major adverse event 30 days after the procedure. The primary feasibility end point was improvement in the IIEF-6 (Erectile Dysfunction Domain) score of 4 points or more. RESULTS: Forty-five lesions were treated with stents in 30 subjects. Procedural success was 100% with no major adverse events through follow-up. The primary feasibility end point (IIEF-6 ϩ4) was achieved by 59.3% (16/27) of intention to treat subjects at 3 and 6 months, and 81% of subjects (17/21) at 1 year. Mean peak systolic velocity on penile Doppler increased from 16.4 cm/s at baseline to 28.8 cm/sec at 3 months, 42 cm/sec at 6 months, and 32.4 cm/sec at 1 year. 5 patients were stented outside the pudendal artery and 4 subjects withdrew from follow up. Angiographic binary restonosis (Ͼ50% lumen diameter stenosis) was found in 11/32 lesions (34.4%). CONCLUSIONS: Among patients with ED and limited response with pharmacologic therapy, percutaneous stent revascularization of the internal pudendal artery is safe and appears promising. However, additional research is needed to determine if pudendal artery stenting is a viable adjunctive treatment for men with vasculogenic ED.
- 1 April 2013
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 189 (4S) , e625
Open Access1526 A NEPHROLITHOMETRIC NOMOGRAM FOR PREDICTING TREATMENT SUCCESS IN PERCUTANEOUS NEPHROLITHOTOMY
Tion in focal atherosclerotic lesions of the internal pudendal arteries (IPAs) among men with erectile dysfunction (ED) and a suboptimal response to phosphodiesterase-5 inhibitors. Zotarolimus is a cytostatic limus drug that minimizes growth of restenotic cells and preserves healthy endothelial cells lining a cobalt chromium stent. METHODS: We performed a prospective, multicenter, singlearmed safety and feasibility trial of 30 male subjects Ͼ 18 years with atherosclerotic ED and a suboptimal response to phosphodiesterase-5 inhibitors. A novel combination of clinical, duplex ultrasound, and invasive angiographic factors were used to determine eligibility for stent therapy. Key inclusion criteria included IIEF-6 Ͻ 21 with at least 4 weeks of PDE5i use, ultrasound PSVs Ͻ 30 cm/sec bilaterally, and angiographic stenosis of one or both IPAs. Key exclusion criteria included non-vascular causes of ED, venous leak as seen on penile Doppler (EDV Ͼ 5 cm/sec), and arteriographic non target lesions of Ͼ 70% stenosis in common iliac or common penile artery. The primary safety end point was any major adverse event 30 days after the procedure. The primary feasibility end point was improvement in the IIEF-6 (Erectile Dysfunction Domain) score of 4 points or more. RESULTS: Forty-five lesions were treated with stents in 30 subjects. Procedural success was 100% with no major adverse events through follow-up. The primary feasibility end point (IIEF-6 ϩ4) was achieved by 59.3% (16/27) of intention to treat subjects at 3 and 6 months, and 81% of subjects (17/21) at 1 year. Mean peak systolic velocity on penile Doppler increased from 16.4 cm/s at baseline to 28.8 cm/sec at 3 months, 42 cm/sec at 6 months, and 32.4 cm/sec at 1 year. 5 patients were stented outside the pudendal artery and 4 subjects withdrew from follow up. Angiographic binary restonosis (Ͼ50% lumen diameter stenosis) was found in 11/32 lesions (34.4%). CONCLUSIONS: Among patients with ED and limited response with pharmacologic therapy, percutaneous stent revascularization of the internal pudendal artery is safe and appears promising. However, additional research is needed to determine if pudendal artery stenting is a viable adjunctive treatment for men with vasculogenic ED.
- 1 February 2013
- Published by Elsevier in European Urology
- Vol. 63 (2) , e25-e26
Reply to Chandra Shekhar Biyani, Andy Myatt, Victor Palit, Neil Burgess and Adrian D. Joyce's Letter to the Editor re: Jean J.M.C.H. de la Rosette, Dedan Opondo, Francisco P.J. Daels, et al., on behalf of the CROES PCNL Study Group. Categorisation of Complications and Validation of the Clavien Score for Percutaneous Nephrolithotomy. Eur Urol 2012;62:246–55
- 1 February 2013
- Published by Elsevier in European Urology
- Vol. 63 (2) , e25-e26
Reply to Chandra Shekhar Biyani, Andy Myatt, Victor Palit, Neil Burgess and Adrian D. Joyce's Letter to the Editor re: Jean J.M.C.H. de la Rosette, Dedan Opondo, Francisco P.J. Daels, et al., on behalf of the CROES PCNL Study Group. Categorisation of Complications and Validation of the Clavien Score for Percutaneous Nephrolithotomy. Eur Urol 2012;62:246–55
- 1 December 2012
- Published by Elsevier in European Urology
- Vol. 62 (6) , 1181-1187
Impact of Case Volumes on the Outcomes of Percutaneous Nephrolithotomy
- 1 December 2012
- Published by Elsevier in European Urology
- Vol. 62 (6) , 1181-1187
Impact of Case Volumes on the Outcomes of Percutaneous Nephrolithotomy
- 6 September 2012
- Published by Springer Nature in World Journal of Urology
- Vol. 30 (5) , 659-664
Partial nephrectomy: Is there an advantage of the self-retaining barbed suture in the perioperative period? A matched case–control comparison
To evaluate the efficacy of the self-retaining barbed suture (SRBS) in renal defect repair during partial nephrectomy (PN), by assessing perioperative outcomes. From June 2010 on we have been using the SRBS for superficial layer closure during open and laparoscopic PN in two European centers. These data were collected prospectively and matched with historical PN cases performed with conventional suture. Cases were matched for PADUA score, surgical approach (laparoscopic or open) and the center where surgery was performed. Comparisons were made in patient characteristics and perioperative outcomes including warm ischemia time (WIT), changes in hemoglobin (Hb), changes in estimated glomerular filtration rate (eGFR) and perioperative complications between the SRBS and non-SRBS groups. Statistical tests of significance were performed using Student’s t test and chi-square test for continuous and categorical variables, respectively. Thirty-one consecutive cases of PN under WIT were performed with SRBS. These cases were matched with cases from the historical database of PN performed with conventional suture. The rate of perioperative complications was statistically significantly lower in the SRBS cohort (6.5 vs. 22.6 %, p = 0.038). Mean ischemia time was 19.6 min (SD, 7.5) in the SRBS group versus 21.8 min (SD, 9.5) in the conventional suture group (p = 0.312). There were no significant differences between groups for postoperative changes in creatinine, eGFR and Hb. Limitations of this study include the absence of randomization and the relative small sample size. SRBS can be safely used during partial nephrectomy. SRBS reduces significantly the number of perioperative complications.
- 6 September 2012
- Published by Springer Nature in World Journal of Urology
- Vol. 30 (5) , 659-664
Partial nephrectomy: Is there an advantage of the self-retaining barbed suture in the perioperative period? A matched case–control comparison
To evaluate the efficacy of the self-retaining barbed suture (SRBS) in renal defect repair during partial nephrectomy (PN), by assessing perioperative outcomes. From June 2010 on we have been using the SRBS for superficial layer closure during open and laparoscopic PN in two European centers. These data were collected prospectively and matched with historical PN cases performed with conventional suture. Cases were matched for PADUA score, surgical approach (laparoscopic or open) and the center where surgery was performed. Comparisons were made in patient characteristics and perioperative outcomes including warm ischemia time (WIT), changes in hemoglobin (Hb), changes in estimated glomerular filtration rate (eGFR) and perioperative complications between the SRBS and non-SRBS groups. Statistical tests of significance were performed using Student’s t test and chi-square test for continuous and categorical variables, respectively. Thirty-one consecutive cases of PN under WIT were performed with SRBS. These cases were matched with cases from the historical database of PN performed with conventional suture. The rate of perioperative complications was statistically significantly lower in the SRBS cohort (6.5 vs. 22.6 %, p = 0.038). Mean ischemia time was 19.6 min (SD, 7.5) in the SRBS group versus 21.8 min (SD, 9.5) in the conventional suture group (p = 0.312). There were no significant differences between groups for postoperative changes in creatinine, eGFR and Hb. Limitations of this study include the absence of randomization and the relative small sample size. SRBS can be safely used during partial nephrectomy. SRBS reduces significantly the number of perioperative complications.
- 31 August 2012
- Published by Elsevier in European Urology
- Vol. 62 (2) , 259-260
Reply from Authors re: Jens J. Rassweiler, Marie-Claire Rassweiler, Maurice-Stephan Michel. Classification of Complications: Is the Clavien-Dindo Classification the Gold Standard? Eur Urol 2012;62:256–8: The Boundary of Surgical Errors and Complications
- 31 August 2012
- Published by Elsevier in European Urology
- Vol. 62 (2) , 259-260
Reply from Authors re: Jens J. Rassweiler, Marie-Claire Rassweiler, Maurice-Stephan Michel. Classification of Complications: Is the Clavien-Dindo Classification the Gold Standard? Eur Urol 2012;62:256–8: The Boundary of Surgical Errors and Complications
- Open Access
- 22 August 2012
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (8) , e43617
Inappropriateness of Medication Prescriptions to Elderly Patients in the Primary Care Setting: A Systematic Review
Inappropriate medication prescription is a common cause of preventable adverse drug events among elderly persons in the primary care setting. The aim of this systematic review is to quantify the extent of inappropriate prescription to elderly persons in the primary care setting. We systematically searched Ovid-Medline and Ovid-EMBASE from 1950 and 1980 respectively to March 2012. Two independent reviewers screened and selected primary studies published in English that measured (in)appropriate medication prescription among elderly persons (>65 years) in the primary care setting. We extracted data sources, instruments for assessing medication prescription appropriateness, and the rate of inappropriate medication prescriptions. We grouped the reported individual medications according to the Anatomical Therapeutic and Chemical (ATC) classification and compared the median rate of inappropriate medication prescription and its range within each therapeutic class. We included 19 studies, 14 of which used the Beers criteria as the instrument for assessing appropriateness of prescriptions. The median rate of inappropriate medication prescriptions (IMP) was 20.5% [IQR 18.1 to 25.6%.]. Medications with largest median rate of inappropriate medication prescriptions were propoxyphene 4.52(0.10–23.30)%, doxazosin 3.96 (0.32 15.70)%, diphenhydramine 3.30(0.02–4.40)% and amitriptiline 3.20 (0.05–20.5)% in a decreasing order of IMP rate. Available studies described unequal sets of medications and different measurement tools to estimate the overall prevalence of inappropriate prescription. Approximately one in five prescriptions to elderly persons in primary care is inappropropriate despite the attention that has been directed to quality of prescription. Diphenhydramine and amitriptiline are the most common inappropriately prescribed medications with high risk adverse events while propoxyphene and doxazoxin are the most commonly prescribed medications with low risk adverse events. These medications are good candidates for being targeted for improvement e.g. by computerized clinical decision support.
- 22 August 2012
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (8) , e43617
Open AccessInappropriateness of Medication Prescriptions to Elderly Patients in the Primary Care Setting: A Systematic Review
Inappropriate medication prescription is a common cause of preventable adverse drug events among elderly persons in the primary care setting. The aim of this systematic review is to quantify the extent of inappropriate prescription to elderly persons in the primary care setting. We systematically searched Ovid-Medline and Ovid-EMBASE from 1950 and 1980 respectively to March 2012. Two independent reviewers screened and selected primary studies published in English that measured (in)appropriate medication prescription among elderly persons (>65 years) in the primary care setting. We extracted data sources, instruments for assessing medication prescription appropriateness, and the rate of inappropriate medication prescriptions. We grouped the reported individual medications according to the Anatomical Therapeutic and Chemical (ATC) classification and compared the median rate of inappropriate medication prescription and its range within each therapeutic class. We included 19 studies, 14 of which used the Beers criteria as the instrument for assessing appropriateness of prescriptions. The median rate of inappropriate medication prescriptions (IMP) was 20.5% [IQR 18.1 to 25.6%.]. Medications with largest median rate of inappropriate medication prescriptions were propoxyphene 4.52(0.10–23.30)%, doxazosin 3.96 (0.32 15.70)%, diphenhydramine 3.30(0.02–4.40)% and amitriptiline 3.20 (0.05–20.5)% in a decreasing order of IMP rate. Available studies described unequal sets of medications and different measurement tools to estimate the overall prevalence of inappropriate prescription. Approximately one in five prescriptions to elderly persons in primary care is inappropropriate despite the attention that has been directed to quality of prescription. Diphenhydramine and amitriptiline are the most common inappropriately prescribed medications with high risk adverse events while propoxyphene and doxazoxin are the most commonly prescribed medications with low risk adverse events. These medications are good candidates for being targeted for improvement e.g. by computerized clinical decision support.
- Top Cited Papers
- 1 August 2012
- Published by Elsevier in European Urology
- Vol. 62 (2) , 246-255
Categorisation of Complications and Validation of the Clavien Score for Percutaneous Nephrolithotomy
- 1 August 2012
- Published by Elsevier in European Urology
- Vol. 62 (2) , 246-255
Top Cited PapersCategorisation of Complications and Validation of the Clavien Score for Percutaneous Nephrolithotomy